NTSAD Virtual Family Conference | 2021 GM2 Sandhoff and Tay-Sachs Breakout

Ruben Giorgino, Head of Clinical Research and Development
Azafaros drug development program



Joel Ellis, PhD, Director of Toxicology
Recursion Pharmaceuticals drug development program



Suyash Prasad, MBBS, MSc, Chief Medical Officer & Head of R&D
Taysha gene therapies clinical trial



Erika De Boever, VP Clinical Development
Sio Gene Therapies clinical trial